<DOC>
	<DOCNO>NCT01994096</DOCNO>
	<brief_summary>Intensive care unit ( ICU ) patient especially risk invasive candidiasis due presence risk factor . It know critically ill patient , alteration function various organ body system influence pharmacokinetics hence plasma concentration drug . A study caspofungin ICU patient find high inter- intra-individual variability caspofungin concentration . Factors cause subtherapeutic caspofungin plasma concentration body weight &gt; 75 kg hypoalbuminemia . Furthermore , efficacy study show low response rate caspofungin among patient high disease severity score . As result alter pharmacokinetics , under- over-exposure caspofungin occur critically ill patient adjust dosage might necessary patient .</brief_summary>
	<brief_title>Optimal Dosage Caspofungin Critically Ill Patients</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Treatment caspofungin . Admission ICU . Age â‰¥ 18 year . Suspected invasive candidiasis , establish physician . Blood sample central venous catheter peripheral cannula possible .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>